Business
Providence Medical Technology Appoints Industry Veteran Jim Hens as Chief Commercial Officer as the Company Continues Rapid Growth Following Publication of Landmark Study
Providence Medical Technology (Providence), a pioneer in spinal fusion surgery technology, today announced the appointment of industry veteran Jim Hens as Chief Commercial Officer.
About this update from Globus Medical, Inc.
[{"type":"text","content":"PLEASANTON, Calif., Feb. 4, 2026 /PRNewswire/ -- Providence Medical Technology (Providence), a pioneer in spinal fusion surgery technology, today announced the appointment of industry veteran Jim Hens as Chief Commercial Officer.","length":229,"tagName":"p"},{"type":"image","alt":"Providence Medical Technology, Inc. (PRNewsfoto/Providence Medical Technology, Inc.)","displaySize":"","headline":null,"caption":"Providence Medical Technology, Inc. (PRNewsfoto/Providence Medical Technology, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":76,"url":"https://media.zenfs.com/en/prnewswire.com/c28d33ee5e22da43520d1c926cbdd7ca"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/zocAftFibA2om1QVTBu9bw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEzNDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/c28d33ee5e22da43520d1c926cbdd7ca","width":400,"height":76}},"href":"https://mma.prnewswire.com/media/2750269/Providence_logo_TM_4000_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Hens has over 25 years of leadership experience in the orthopedic and spine industries and is joining the company to spearhead its commercial expansion and continue the company's industry-leading growth trajectory. He brings a proven track record of scaling medical device organizations, most recently as Managing Director of U.S. for Silony Spine, where he oversaw all U.S. operations. Before that, he was a General Manager at NuVasive (acquired by Globus Medical Inc. in 2023), where he managed its largest division for three years, achieving record growth.","length":563,"tagName":"p"},{"type":"text","content":"Hens' appointment comes as Providence extends its rapid growth following publication of its landmark 202-patient FUSE Study in the journal Spine. The prospective, randomized controlled trial is the first study of its kind and demonstrates that multi-level Circumferential Cervical Fusion (CCF) — the fusion of all joints of the spinal segment — delivered clinically superior outcomes when compared to the more commonly performed Anterior Cervical Discectomy and Fusion (ACDF).1 ","length":481,"tagName":"p"},{"type":"text","content":""The company is at an exciting inflection point where Providence's clinical evidence is accelerating market demand," said Scott Lynch, Chief Product ...